Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
529 hedge funds and large institutions have $12.9B invested in Abiomed Inc in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 198 increasing their positions, 179 reducing their positions, and 75 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 198 | Existing positions reduced: 179
9% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 75
0% more funds holding
Funds holding: 529 → 529 (0)
28% less capital invested
Capital invested by funds: $17.9B → $12.9B (-$5.03B)
35% less funds holding in top 10
Funds holding in top 10: 20 → 13 (-7)
37% less call options, than puts
Call options by funds: $143M | Put options by funds: $227M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$182M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$142M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$140M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$91.8M |
| 5 |
Janus Henderson Group
London,
|
+$71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$177M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$163M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$146M |
| 4 |
Two Sigma Advisers
New York
|
-$79.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$79.3M |
ABMD Hedge Fund Activity: Q4 2018 in Review
529 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2018, worth a combined $12.9B — down 28% from $17.9B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new ABMD positions and 75 closed out — a net gain of 7 holders — while 198 added to existing stakes and 179 trimmed.
The largest buyer was Winslow Capital Management, adding an estimated $182M. The largest seller was Marshall Wace North America, cutting an estimated $177M.
- 529 institutional investors held Abiomed Inc (ABMD) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $12.9B of Abiomed Inc stock for Q4 2018, down 28% quarter-over-quarter.
- 82 funds opened new Abiomed Inc positions in Q4 2018 and 75 closed out, a net change of +7 holders.
- The largest Abiomed Inc buyer in Q4 2018 was Winslow Capital Management, an estimated $182M added.
- The largest Abiomed Inc seller in Q4 2018 was Marshall Wace North America, an estimated $177M sold.
Based on aggregated 13F filings for Q4 2018.